icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
Boston MA
November 2019
Back grey_arrow_rt.gif
 
 
 
Obeticholic Acid Treatment in Patients with Non-alcoholic Steatohepatitis: A Secondary Analysis of the REGENERATE Study Across Fibrosis Stages
 
 
  AASLD 2019 Nov 8-12 Boston
 
Arun J. Sanyal, Vlad Ratziu, Rohit Loomba, Mary Rinella, Quentin M. Anstee, Zachary Goodman, Pierre Bedossa, Mandana Khalili, Jerome Boursier, Laura Stinton, Giulio Marchesini, Michael Allison, Jacob George, Perttu Arkkila, Luna Zaru, Leigh MacConell, Reshma Shringarpure, Zobair M. Younossi on behalf of the REGENERATE Study Investigators
 
EASL-2019: Positive Results from REGENERATE: A Phase 3 International, Randomized, Placebo-Controlled Study Evaluating Obeticholic Acid Treatment for NASH

1203191

1203192

1203193

1203194

1203195

1203196

ack